Biohaven Pharmaceuticals, Inc.
Clinical trials sponsored by Biohaven Pharmaceuticals, Inc., explained in plain language.
-
New hope for rare brain disorder: drug trial targets movement problems
Symptom relief CompletedThis study tested a daily pill called troriluzole in 141 adults with spinocerebellar ataxia, a rare brain disease that affects balance and coordination. Participants took either the drug or a placebo for 8 weeks. The main goal was to see if the drug improved scores on a standard …
Phase: PHASE2, PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 17, 2026 10:08 UTC
-
New OCD drug shows promise in large trial
Symptom relief CompletedThis study tested whether adding troriluzole to standard OCD medications helps reduce symptoms in adults who still had moderate to severe OCD. Over 400 participants took either troriluzole or a placebo for several weeks. The main goal was to see if the drug improved OCD severity …
Phase: PHASE2, PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 17, 2026 10:08 UTC
-
Could this pill ease OCD symptoms when standard meds fall short?
Symptom relief CompletedThis study tested whether adding troriluzole to standard OCD medication works better than a placebo. It involved 456 adults with OCD who had not fully responded to their current treatment. The main goal was to see if the drug reduces OCD symptoms and is safe to use.
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 01, 2026 16:01 UTC